Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 5 |
Descriptor
| Attention Deficit Disorders | 5 |
| Drug Therapy | 5 |
| Hyperactivity | 5 |
| Children | 4 |
| Patients | 4 |
| Adolescents | 2 |
| Incidence | 2 |
| Outcomes of Treatment | 2 |
| Symptoms (Individual… | 2 |
| Attention Span | 1 |
| Behavior Change | 1 |
| More ▼ | |
Source
| Journal of the American… | 2 |
| Developmental Medicine &… | 1 |
| Journal of Attention Disorders | 1 |
| Journal of the American… | 1 |
Author
| Allen, Albert J. | 5 |
| Bangs, Mark E. | 2 |
| Dunn, David | 2 |
| Zhang, Shuyu | 2 |
| Acharya, Nayan | 1 |
| Ball, Susan | 1 |
| Budman, Cathy L. | 1 |
| Busner, Joan | 1 |
| Coffey, Barbara J. | 1 |
| Desaiah, Durisala | 1 |
| Dickson, Ruth | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 5 |
| Reports - Research | 5 |
Education Level
Audience
Location
| United States | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Direct linkBangs, Mark E.; Tauscher-Wisniewski, Sitra; Polzer, John; Zhang, Shuyu; Acharya, Nayan; Desaiah, Durisala; Trzepacz, Paula T.; Allen, Albert J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2008
A study to examine suicide-related events in acute, double-blind, and placebo controlled trials with atomoxetine is conducted. Results conclude that the incidences of suicide were more frequent in children suffering from ADHD treated with atomoxetine as compared to those treated with placebo.
Descriptors: Suicide, Patients, Drug Therapy, Children
Spencer, Thomas J.; Sallee, F. Randy; Gilbert, Donald L.; Dunn, David W.; McCracken, James T.; Coffey, Barbara J.; Budman, Cathy L.; Ricardi, Randall K.; Leonard, Henrietta L.; Allen, Albert J.; Milton, Denai R.; Feldman, Peter D.; Kelsey, Douglas K.; Geller, Daniel A.; Linder, Steven L.; Lewis, Donald W.; Winner, Paul K.; Kurlan, Roger M.; Mintz, Mark – Journal of Attention Disorders, 2008
Objective: This study examines changes in severity of tics and ADHD during atomoxetine treatment in ADHD patients with Tourette syndrome (TS). Method: Subjects (7-17 years old) with ADHD ("Diagnostic and Statistical Manual of Mental Disorders, DSM-IV") and TS were randomly assigned to double-blind treatment with placebo (n = 56) or atomoxetine…
Descriptors: Metabolism, Attention Deficit Disorders, Patients, Severity (of Disability)
Wernicke, Joachim F.; Holdridge, Karen Chilcott; Jin, Ling; Edison, Timothy; Zhang, Shuyu; Bangs, Mark E.; Allen, Albert J.; Ball, Susan; Dunn, David – Developmental Medicine & Child Neurology, 2007
The comorbidity of seizures, epilepsy, and attention-deficit-hyperactivity disorder (ADHD) prompted the examination of whether atomoxetine use for ADHD is associated with an increased risk of seizures. Seizures and seizure-related symptoms were reviewed from two independent Eli Lilly and Company databases: the atomoxetine clinical trials database…
Descriptors: Epilepsy, Incidence, Seizures, Hyperactivity
Kratochvil, Christopher J.; Michelson, David; Newcorn, Jeffrey H.; Weiss, Margaret D.; Busner, Joan; Moore, Rodney J.; Ruff, Dustin D.; Ramsey, Janet; Dickson, Ruth; Turgay, Atilla; Saylor, Keith E.; Luber, Stephen; Vaughan, Brigette; Allen, Albert J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2007
Objective: To assess the utility and tolerability of higher than standard atomoxetine doses to treat attention-deficit/hyperactivity disorder (ADHD). Method: Two randomized, double-blind trials of atomoxetine nonresponders ages 6 to 16 years were conducted comparing continued treatment with same-dose atomoxetine to treatment using greater than…
Descriptors: Hyperactivity, Attention Deficit Disorders, Rating Scales, Patients
Peer reviewedWeiss, Margaret; Tannock, Rosemary; Kratochvil, Christopher; Dunn, David; Velez-Borras, Jesus; Thomason, Christine; Tamura, Roy; Kelsey, Douglas; Stevens, Linda; Allen, Albert J. – Journal of the American Academy of Child and Adolescent Psychiatry, 2005
Objective: Five studies have demonstrated the effectiveness of atomoxetine compared with placebo in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) based on parent reports. The primary objective of this clinical trial was to assess the efficacy of once-daily atomoxetine compared with placebo using teacher reports. Method: One…
Descriptors: Measures (Individuals), Symptoms (Individual Disorders), Student Behavior, Hyperactivity
